We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Indomethacin and staurosporine reverse α<sub>2</sub> inhibition of water transport in rat IMCD.
- Authors
Rouch, Alexander J.; Kudo, Lúcia H.
- Abstract
Indomethacin and staurosporine reverse a2 inhibition of water transport in rat IMCD. These studies were conducted to determine if the prostaglandin-synthesis inhibitor indomethacin or the protein kinase C (PKC) inhibitor staurosporine affect the inhibition of osmotic water permeability (P,) by the alpha-2 (α) agonist dexmedetomidine in the rat inner medullary collecting duct (IMCD). Terminal IMCDs from Wistar rats were perfused and Pf was increased with either 220 pM arginine vasopressin (AVP) or 0.1 mM 8-chlorophenylthio cyclic adenosine monophosphate (8CPTcAMP), All agents were added to the bathing solution. Dexmedetomidine at 100 nM inhibited both AVP- and 8CPTcAMPslimulated Pf. When Pf was increased by AVP, indomethacin at 0.1 mM or 5 /μM reversed the dexmedetomidine-induced inhibition by 68% and 43%, respectively. When Pf was increased by 8CPTcAMP, indomethacin at 0.1 mM or 5 μm reversed inhibition by 83% and 70%, respectively. Indomethacin increased AVP and 8CPT cAMP-stimulated Pf by 20 to 30% and dexmedetomidine inhibited the AVP+ indomeithacin-stimulated ,Pf. Staurosporine at 10 nM yielded similar results. Results suggest that PKC and prostaglandins are involved in the a, mediated mechanism, and staurosporine and indomethacin-sensitive cellular mediators modulate basal Pf.
- Subjects
INDOMETHACIN; PROTEIN kinases; PITUITARY hormones; PROSTANOIDS; NONSTEROIDAL anti-inflammatory agents; PROSTAGLANDINS; INFLAMMATORY mediators
- Publication
Kidney International, 1997, Vol 52, Issue 5, p1351
- ISSN
0085-2538
- Publication type
Article
- DOI
10.1038/ki.1997.460